Business Description
This fund aims to deliver three times the daily return of a biotechnology industry index by putting at least 80% of its assets into investments such as swaps, index securities, and related ETFs. The underlying index tracks the performance of biotech companies as defined by the Global Industry Classification Standards. Because the fund concentrates its holdings rather than spreading them broadly, it carries a higher level of risk than a typical diversified fund.
